The impact of ICD-9-CM code rank order on the estimated prevalence of Clostridium difficile infections
- PMID: 21653298
- PMCID: PMC3110281
- DOI: 10.1093/cid/cir246
The impact of ICD-9-CM code rank order on the estimated prevalence of Clostridium difficile infections
Abstract
Background: US estimates of the Clostridium difficile infection (CDI) burden have utilized International Classification of Disease, Ninth Revision, Clinical Modification (ICD-9-CM) diagnosis codes. Whether ICD-9-CM code rank order affects CDI prevalence estimates is important because the National Hospital Discharge Survey (NHDS) and the Nationwide Inpatient Sample (NIS) have varying limits on the number of ICD-9-CM codes collected.
Methods: ICD-9-CM codes for CDI (008.45), C. difficile toxin assay results, and dates of admission and discharge were collected from electronic hospital databases for adult patients admitted to 4 hospitals in the United States from July 2000 through June 2006. CDI prevalence per 1000 discharges was calculated and compared for NHDS and NIS limits and toxin assay results from the same hospitals. CDI prevalence estimates were compared using the χ(2) test, and the test of equality was used to compare slopes.
Results: CDI prevalence measured by NIS criteria was significantly higher than that measured using NHDS criteria (10.7 cases per 1000 discharges versus 9.4 cases per 1000 discharges; P<.001) in the 4 hospitals. CDI prevalence measured by toxin assay results was 9.4 cases per 1000 discharges (P=.57 versus NHDS). However, the CDI prevalence increased more rapidly over time when measured according to the NHDS criteria than when measured according to toxin assay results (β=1.09 versus 0.84; P=.008).
Conclusions: Compared with the NHDS definition, the NIS definition captured 12% more CDI cases and reported significantly higher CDI rates. Rates calculated using toxin assay results were not different from rates calculated using NHDS criteria, but CDI prevalence appeared to increase more rapidly when measured by NHDS criteria than when measured by toxin assay results.
© The Author 2011. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved.
Figures
Similar articles
-
Multicenter study of surveillance for hospital-onset Clostridium difficile infection by the use of ICD-9-CM diagnosis codes.Infect Control Hosp Epidemiol. 2010 Mar;31(3):262-8. doi: 10.1086/650447. Infect Control Hosp Epidemiol. 2010. PMID: 20100085 Free PMC article.
-
Use of International Classification of Diseases, Ninth Revision, Clinical Modification codes and medication use data to identify nosocomial Clostridium difficile infection.Infect Control Hosp Epidemiol. 2009 Nov;30(11):1070-6. doi: 10.1086/606164. Infect Control Hosp Epidemiol. 2009. PMID: 19803724
-
National age group trends in Clostridium difficile infection incidence and health outcomes in United States Community Hospitals.BMC Infect Dis. 2016 Nov 17;16(1):682. doi: 10.1186/s12879-016-2027-8. BMC Infect Dis. 2016. PMID: 27855653 Free PMC article.
-
Rapid detection of Clostridium difficile toxins and laboratory diagnosis of Clostridium difficile infections.Infection. 2017 Jun;45(3):255-262. doi: 10.1007/s15010-016-0940-9. Epub 2016 Sep 6. Infection. 2017. PMID: 27601055 Review.
-
Burden of Clostridium difficile on the healthcare system.Clin Infect Dis. 2012 Aug;55 Suppl 2(Suppl 2):S88-92. doi: 10.1093/cid/cis335. Clin Infect Dis. 2012. PMID: 22752870 Free PMC article. Review.
Cited by
-
Time trends and predictors of laboratory-confirmed recurrent and severe Clostridioides difficile infections in Manitoba: a population-based study.CMAJ Open. 2020 Nov 16;8(4):E737-E746. doi: 10.9778/cmajo.20190191. Print 2020 Oct-Dec. CMAJ Open. 2020. PMID: 33199507 Free PMC article.
-
Antibiotic Prescribing Choices and Their Comparative C. Difficile Infection Risks: A Longitudinal Case-Cohort Study.Clin Infect Dis. 2021 Mar 1;72(5):836-844. doi: 10.1093/cid/ciaa124. Clin Infect Dis. 2021. PMID: 32069358 Free PMC article.
-
Direct cost of health care for individuals with community associated Clostridium difficile infections: A population-based cohort study.PLoS One. 2019 Nov 8;14(11):e0224609. doi: 10.1371/journal.pone.0224609. eCollection 2019. PLoS One. 2019. PMID: 31703080 Free PMC article.
-
Evaluating the impact of expanding the number of diagnosis codes reported in inpatient discharge databases on the counts and rates of birth defects.J Am Med Inform Assoc. 2018 Nov 1;25(11):1524-1533. doi: 10.1093/jamia/ocy096. J Am Med Inform Assoc. 2018. PMID: 30124843 Free PMC article.
-
The Impact of Bariatric Surgery on Short Term Risk of Clostridium Difficile Admissions.Obes Surg. 2018 Jul;28(7):2006-2013. doi: 10.1007/s11695-018-3131-1. Obes Surg. 2018. PMID: 29404936
References
-
- Muto CA, Pokrywka M, Shutt K, et al. A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use. Infect Control Hosp Epidemiol. 2005;26:273–80. - PubMed
-
- Pepin J, Saheb N, Coulombe MA, et al. Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. Clin Infect Dis. 2005;41:1254–60. - PubMed
-
- McDonald LC, Killgore GE, Thompson A, et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med. 2005;353:2433–1. - PubMed
